CA
CORT icon

Cetera Advisors’s Corcept Therapeutics CORT Stock Holding History

Cetera Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$340K Buy
+13,502
New +$319K ﹤0.01% 1851

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Cetera Advisors's CORT Position: Q1 2024 in Review

Cetera Advisors opened a new position in Corcept Therapeutics (CORT) in Q1 2024: 13,502 shares worth $340K. The stake represents ﹤0.01% of the portfolio and ranks #1851 among its holdings.

287 funds tracked by Wall St. Rank hold CORT as of Q1 2024.

  • Cetera Advisors held 13,502 shares of Corcept Therapeutics worth $340K as of Q1 2024.
  • Corcept Therapeutics was a new Cetera Advisors position in Q1 2024.
  • Corcept Therapeutics made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #1851 holding.
  • 287 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.